MELCOR DEVELOPMENTS LTD (MRD.CA) Fundamental Analysis & Valuation

TSX:MRD • CA5854671032

Current stock price

18.25 CAD
-0.12 (-0.65%)
Last:

This MRD.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. MRD.CA Profitability Analysis

1.1 Basic Checks

  • In the past year MRD was profitable.
  • In the past year MRD had a positive cash flow from operations.
  • Each year in the past 5 years MRD has been profitable.
  • Each year in the past 5 years MRD had a positive operating cash flow.
MRD.CA Yearly Net Income VS EBIT VS OCF VS FCFMRD.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M

1.2 Ratios

  • MRD has a Return On Assets of 2.83%. This is comparable to the rest of the industry: MRD outperforms 55.17% of its industry peers.
  • With a Return On Equity value of 4.58%, MRD perfoms like the industry average, outperforming 58.62% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 4.47%, MRD is in the better half of the industry, outperforming 72.41% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for MRD is significantly below the industry average of 18.70%.
  • The 3 year average ROIC (3.75%) for MRD is below the current ROIC(4.47%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.83%
ROE 4.58%
ROIC 4.47%
ROA(3y)2.47%
ROA(5y)2.84%
ROE(3y)4.16%
ROE(5y)5.02%
ROIC(3y)3.75%
ROIC(5y)3.37%
MRD.CA Yearly ROA, ROE, ROICMRD.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6

1.3 Margins

  • MRD's Profit Margin of 14.13% is fine compared to the rest of the industry. MRD outperforms 65.52% of its industry peers.
  • MRD's Profit Margin has improved in the last couple of years.
  • Looking at the Operating Margin, with a value of 37.61%, MRD is in the better half of the industry, outperforming 68.97% of the companies in the same industry.
  • MRD's Operating Margin has improved in the last couple of years.
  • MRD has a Gross Margin (46.19%) which is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of MRD has remained more or less at the same level.
Industry RankSector Rank
OM 37.61%
PM (TTM) 14.13%
GM 46.19%
OM growth 3Y0.67%
OM growth 5Y2.8%
PM growth 3Y-27.44%
PM growth 5Y22.75%
GM growth 3Y-1.91%
GM growth 5Y1.3%
MRD.CA Yearly Profit, Operating, Gross MarginsMRD.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

7

2. MRD.CA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MRD is destroying value.
  • MRD has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for MRD has been reduced compared to 5 years ago.
  • MRD has a better debt/assets ratio than last year.
MRD.CA Yearly Shares OutstandingMRD.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
MRD.CA Yearly Total Debt VS Total AssetsMRD.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

  • MRD has an Altman-Z score of 1.80. This is a bad value and indicates that MRD is not financially healthy and even has some risk of bankruptcy.
  • MRD has a Altman-Z score of 1.80. This is in the better half of the industry: MRD outperforms 65.52% of its industry peers.
  • The Debt to FCF ratio of MRD is 6.49, which is on the high side as it means it would take MRD, 6.49 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 6.49, MRD belongs to the top of the industry, outperforming 86.21% of the companies in the same industry.
  • MRD has a Debt/Equity ratio of 0.43. This is a healthy value indicating a solid balance between debt and equity.
  • With a decent Debt to Equity ratio value of 0.43, MRD is doing good in the industry, outperforming 68.97% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 6.49
Altman-Z 1.8
ROIC/WACC0.63
WACC7.13%
MRD.CA Yearly LT Debt VS Equity VS FCFMRD.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • A Current Ratio of 5.23 indicates that MRD has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 5.23, MRD belongs to the top of the industry, outperforming 89.66% of the companies in the same industry.
  • A Quick Ratio of 5.23 indicates that MRD has no problem at all paying its short term obligations.
  • MRD's Quick ratio of 5.23 is amongst the best of the industry. MRD outperforms 89.66% of its industry peers.
Industry RankSector Rank
Current Ratio 5.23
Quick Ratio 5.23
MRD.CA Yearly Current Assets VS Current LiabilitesMRD.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

4

3. MRD.CA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 76.68% over the past year.
  • Measured over the past years, MRD shows a very strong growth in Earnings Per Share. The EPS has been growing by 41.17% on average per year.
  • The Revenue has grown by 17.47% in the past year. This is quite good.
  • Measured over the past years, MRD shows a quite strong growth in Revenue. The Revenue has been growing by 12.60% on average per year.
EPS 1Y (TTM)76.68%
EPS 3Y-11.39%
EPS 5Y41.17%
EPS Q2Q%-1.86%
Revenue 1Y (TTM)17.47%
Revenue growth 3Y19.32%
Revenue growth 5Y12.6%
Sales Q2Q%9.72%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MRD.CA Yearly Revenue VS EstimatesMRD.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
MRD.CA Yearly EPS VS EstimatesMRD.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 0.5 1 1.5 2

5

4. MRD.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 9.71, which indicates a very decent valuation of MRD.
  • Based on the Price/Earnings ratio, MRD is valued a bit cheaper than the industry average as 79.31% of the companies are valued more expensively.
  • When comparing the Price/Earnings ratio of MRD to the average of the S&P500 Index (26.78), we can say MRD is valued rather cheaply.
Industry RankSector Rank
PE 9.71
Fwd PE N/A
MRD.CA Price Earnings VS Forward Price EarningsMRD.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • 96.55% of the companies in the same industry are more expensive than MRD, based on the Enterprise Value to EBITDA ratio.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of MRD indicates a rather cheap valuation: MRD is cheaper than 89.66% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 6.49
EV/EBITDA 6.57
MRD.CA Per share dataMRD.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

  • The decent profitability rating of MRD may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.24
EPS Next 2YN/A
EPS Next 3YN/A

7

5. MRD.CA Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 3.27%, MRD has a reasonable but not impressive dividend return.
  • MRD's Dividend Yield is a higher than the industry average which is at 2.89.
  • MRD's Dividend Yield is rather good when compared to the S&P500 average which is at 1.83.
Industry RankSector Rank
Dividend Yield 3.27%

5.2 History

  • The dividend of MRD is nicely growing with an annual growth rate of 7.10%!
  • MRD has been paying a dividend for at least 10 years, so it has a reliable track record.
  • The dividend of MRD decreased in the last 3 years.
Dividend Growth(5Y)7.1%
Div Incr Years2
Div Non Decr Years2
MRD.CA Yearly Dividends per shareMRD.CA Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6

5.3 Sustainability

  • 24.97% of the earnings are spent on dividend by MRD. This is a low number and sustainable payout ratio.
  • MRD's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP24.97%
EPS Next 2YN/A
EPS Next 3YN/A
MRD.CA Yearly Income VS Free CF VS DividendMRD.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M 60M 80M
MRD.CA Dividend Payout.MRD.CA Dividend Payout, showing the Payout Ratio.MRD.CA Dividend Payout.PayoutRetained Earnings

MRD.CA Fundamentals: All Metrics, Ratios and Statistics

MELCOR DEVELOPMENTS LTD

TSX:MRD (4/10/2026, 7:00:00 PM)

18.25

-0.12 (-0.65%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)03-10
Earnings (Next)05-07
Inst Owners8.79%
Inst Owner ChangeN/A
Ins Owners14.36%
Ins Owner ChangeN/A
Market Cap548.60M
Revenue(TTM)410.55M
Net Income(TTM)58.02M
Analysts45.71
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.27%
Yearly Dividend0.48
Dividend Growth(5Y)7.1%
DP24.97%
Div Incr Years2
Div Non Decr Years2
Ex-Date03-20
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 9.71
Fwd PE N/A
P/S 1.34
P/FCF 6.49
P/OCF 5.86
P/B 0.43
P/tB 0.43
EV/EBITDA 6.57
EPS(TTM)1.88
EY10.3%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)2.81
FCFY15.41%
OCF(TTM)3.11
OCFY17.06%
SpS13.66
BVpS42.18
TBVpS42.18
PEG (NY)N/A
PEG (5Y)0.24
Graham Number42.24
Profitability
Industry RankSector Rank
ROA 2.83%
ROE 4.58%
ROCE 7.74%
ROIC 4.47%
ROICexc 4.64%
ROICexgc 4.78%
OM 37.61%
PM (TTM) 14.13%
GM 46.19%
FCFM 20.6%
ROA(3y)2.47%
ROA(5y)2.84%
ROE(3y)4.16%
ROE(5y)5.02%
ROIC(3y)3.75%
ROIC(5y)3.37%
ROICexc(3y)3.85%
ROICexc(5y)3.47%
ROICexgc(3y)3.97%
ROICexgc(5y)3.58%
ROCE(3y)6.48%
ROCE(5y)5.82%
ROICexgc growth 3Y21.85%
ROICexgc growth 5Y15.94%
ROICexc growth 3Y22.44%
ROICexc growth 5Y15.93%
OM growth 3Y0.67%
OM growth 5Y2.8%
PM growth 3Y-27.44%
PM growth 5Y22.75%
GM growth 3Y-1.91%
GM growth 5Y1.3%
F-Score9
Asset Turnover0.2
Health
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 6.49
Debt/EBITDA 3.53
Cap/Depr 779.76%
Cap/Sales 2.2%
Interest Coverage 250
Cash Conversion 60.15%
Profit Quality 145.74%
Current Ratio 5.23
Quick Ratio 5.23
Altman-Z 1.8
F-Score9
WACC7.13%
ROIC/WACC0.63
Cap/Depr(3y)1306.94%
Cap/Depr(5y)1393.52%
Cap/Sales(3y)4.72%
Cap/Sales(5y)5.74%
Profit Quality(3y)143.65%
Profit Quality(5y)103.88%
High Growth Momentum
Growth
EPS 1Y (TTM)76.68%
EPS 3Y-11.39%
EPS 5Y41.17%
EPS Q2Q%-1.86%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)17.47%
Revenue growth 3Y19.32%
Revenue growth 5Y12.6%
Sales Q2Q%9.72%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y21.71%
EBIT growth 3Y20.11%
EBIT growth 5Y15.75%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y3.74%
FCF growth 3Y274.49%
FCF growth 5Y24.32%
OCF growth 1Y-5.13%
OCF growth 3Y72.12%
OCF growth 5Y11.99%

MELCOR DEVELOPMENTS LTD / MRD.CA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of MELCOR DEVELOPMENTS LTD (MRD.CA) stock?

ChartMill assigns a fundamental rating of 6 / 10 to MRD.CA.


Can you provide the valuation status for MELCOR DEVELOPMENTS LTD?

ChartMill assigns a valuation rating of 7 / 10 to MELCOR DEVELOPMENTS LTD (MRD.CA). This can be considered as Undervalued.


How profitable is MELCOR DEVELOPMENTS LTD (MRD.CA) stock?

MELCOR DEVELOPMENTS LTD (MRD.CA) has a profitability rating of 6 / 10.


What are the PE and PB ratios of MELCOR DEVELOPMENTS LTD (MRD.CA) stock?

The Price/Earnings (PE) ratio for MELCOR DEVELOPMENTS LTD (MRD.CA) is 9.71 and the Price/Book (PB) ratio is 0.43.


Can you provide the dividend sustainability for MRD stock?

The dividend rating of MELCOR DEVELOPMENTS LTD (MRD.CA) is 5 / 10 and the dividend payout ratio is 24.97%.